thebench.bio #1 Ecosystem for the Bio-Tech Industry

Clinical Daily Summary

Clinical Daily Summary: What Happened on October 25, 2026

ESMO features two Cyclin E1 candidates for ovarian cancer

  • Updated
  • Read from 2 articles, 2 publications
  • P

Today in brief

ESMO26 included data on two candidates targeting Cyclin E1 in platinum-resistant ovarian cancer.1 The VOLGA headline focused on perioperative bladder cancer therapy at the conference.2